Preclinical News and Research

RSS
Humabs BioMed reports clinical milestone in medImmune partnership

Humabs BioMed reports clinical milestone in medImmune partnership

Administration of selenide protects heart tissue post cardiac arrest, shows study

Administration of selenide protects heart tissue post cardiac arrest, shows study

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

New simeprevir clinical data to be presented at EASL's International Liver Congress 2015

New simeprevir clinical data to be presented at EASL's International Liver Congress 2015

National MS Society commits $28 million to support new MS research projects, training awards

National MS Society commits $28 million to support new MS research projects, training awards

Nabriva Therapeutics completes $120 million Series B financing

Nabriva Therapeutics completes $120 million Series B financing

MabVax closes $11.6 million in private placement

MabVax closes $11.6 million in private placement

New biodegradable membrane reduces wound healing time by 50%

New biodegradable membrane reduces wound healing time by 50%

Nanoparticle technique inhibits tumor growth, prolongs survival in animal models

Nanoparticle technique inhibits tumor growth, prolongs survival in animal models

ImmunoClin receives controlled drug license to supply, produce schedule 1 drugs in UK

ImmunoClin receives controlled drug license to supply, produce schedule 1 drugs in UK

Study: APOSEC protein concentrate reduces severity of damage after spinal cord injuries

Study: APOSEC protein concentrate reduces severity of damage after spinal cord injuries

Selvita commences IND-enabling studies for its first oncology drug candidate

Selvita commences IND-enabling studies for its first oncology drug candidate

NIH awards $2.1 million grant to counter antibiotic resistance in Gram-negative bacteria

NIH awards $2.1 million grant to counter antibiotic resistance in Gram-negative bacteria

Aeterna Zentaris inks Material Transfer Agreement with MUSC

Aeterna Zentaris inks Material Transfer Agreement with MUSC

Biomedical researchers successfully convert microbubble technology into nanoparticles

Biomedical researchers successfully convert microbubble technology into nanoparticles

Compact MRI and multimodality: an interview with Bernard Siow, UCL

Compact MRI and multimodality: an interview with Bernard Siow, UCL

Patient with severe Alzheimer's shows promising benefits during treatment with Bryostatin drug

Patient with severe Alzheimer's shows promising benefits during treatment with Bryostatin drug

Cantrixil proves highly effective at killing human ovarian stem cells in pre-clinical study

Cantrixil proves highly effective at killing human ovarian stem cells in pre-clinical study

CRT, BioInvent, and University of Southampton partner to develop new immunotherapy treatments for cancer

CRT, BioInvent, and University of Southampton partner to develop new immunotherapy treatments for cancer

Fujifilm enters into definitive agreement to acquire Cellular Dynamics International

Fujifilm enters into definitive agreement to acquire Cellular Dynamics International

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.